← All diseases Cancer

Lung cancer (small cell)

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest level of evidence only (174)Meta-analysis (63)Treatment guideline (1)Randomized trial (47)Systematic review (37)Phase 3 study (26)Clinical trial (664)Review article (254)Early study (phase 1 or 2) (69)Case description (158)Laboratory or animal research (71)Commentary or editorial (80)Retracted publication (17) Studies currently seeking participants only (63)

Filter

Publications and studies (3295)

• Development and Evaluation of Paclitaxel-Loaded Aerosol Nanocomposite Microparticles and Their Efficacy Against Air-Grown Lung Cancer Tumor Spheroids. (2019/12/09) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [Acute neuropsychiatry: a confused patient and a puzzled doctor]. (2019/12/05) ♡
• [Lung cancer in Eastern Morocco: where do we stand?]. (2019/12/05) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Correlation of prechemotherapy urinary megalin ectodomain (A-megalin) levels with the development of cisplatin-induced nephrotoxicity: a prospective observational study. (2019/12/02) ♡
• In silico identification of thiostrepton as an inhibitor of cancer stem cell growth and an enhancer for chemotherapy in non-small-cell lung cancer. (2019/12/01) ♡
• Compound Kushen injection plus platinum-based chemotherapy for stage IIIB/IV non-small cell lung cancer: A protocol for meta-analysis of randomized clinical trials following the PRISMA guidelines. (2019/12/01) ♡
• Ursolic acid promotes apoptosis and mediates transcriptional suppression of CT45A2 gene expression in non-small-cell lung carcinoma harbouring EGFR T790M mutations. (2019/12/01) ♡
• Accuracy of Resting Energy Expenditure Predictive Equations in Patients With Cancer. (2019/12/01) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Cancer cachexia in thoracic malignancy: a narrative review. (2019/12/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Exploring the dietary protein intake and skeletal muscle during first-line anti-neoplastic treatment in patients with non-small cell lung cancer. (2019/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. A first attempt to establish a definition of oligometastatic non-small cell lung cancer by a European consensus group. (2019/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Neoadjuvant versus adjuvant chemotherapy for resectable non-small cell lung cancer debate revisited. (2019/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Local consolidative therapy for oligometastatic non-small cell lung cancer. (2019/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. What is synchronous oligometastatic non-small cell lung cancer? (2019/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Neoadjuvant vs. adjuvant chemotherapy in locally advanced non-small cell lung cancer-is timing everything? (2019/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Targeted next-generation sequencing to assess tumor mutation burden: ready for prime-time in non-small cell lung cancer? (2019/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Is first-line pembrolizumab appropriate for all patients with metastatic non-squamous histology non-small cell lung cancer patients? (2019/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Myeloid-derived suppressor cell-dependent inhibition of B cell responses in non-small cell lung cancer. (2019/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Looking for the high way in EGFR-positive non-small cell lung cancer through the evaluation of survival endpoints. (2019/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Is the game over for PD-1 inhibitors in EGFR mutant non-small cell lung cancer? (2019/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Surveillance imaging for non-small cell lung cancer: mounting evidence that less is more. (2019/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Impact of surveillance frequency on survival in non-small cell lung cancer (NSCLC) survivors. (2019/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Broad-based genomic sequencing in advanced non-small cell lung cancer in the dock. (2019/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Impact of baseline steroids on efficacy of programmed cell death-1 (PD-1) and programmed death-ligand 1 (PD-L1) blockade in patients with advanced non-small cell lung cancer. (2019/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Erlotinib as standard adjuvant therapy for resectable EGFR mutation-positive non-small cell lung cancer. (2019/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Brigatinib for anaplastic lymphoma kinase-tyrosine kinase inhibitor naïve anaplastic lymphoma kinase-positive advanced non-small cell lung cancer: an effective but still broken option. (2019/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Lorlatinib: an additional option for ALK-positive non-small cell lung cancer? (2019/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Adjuvant EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer: still an investigational approach. (2019/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Minimal residual disease after radical surgery in EGFR-mutant non-small cell lung cancer. (2019/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. The importance of the false-negative rate to validate a staging protocol for non-small cell lung cancer. (2019/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. KEYNOTE-042 rolls back programmed cell death ligand 1 threshold for non-small cell lung cancer pembrolizumab monotherapy without new insight into those deriving benefit. (2019/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Local consolidative therapy for oligometastatic patients with stage IV non-small cell lung cancer may improve survival, but unanswered questions remain. (2019/12/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Combination immune checkpoint inhibitors with platinum-based chemotherapy in advanced non-small cell lung cancer: what's known and what's next. (2019/12/01) ♡
• The analysis of pharmacokinetic and pharmacogenomic impact on gefitinib efficacy in advanced non-small cell lung cancer patients: results from a prospective cohort study. (2019/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [A Case of Mesenteric Hematoma Caused by Abdominal Metastasis of Small Cell Lung Carcinoma]. (2019/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [Small Intestinal Metastasis from Lung Cancer with Infiltration into Other Organs-Review of the Literature]. (2019/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [A Case of Gastric Endocrine Carcinoma with a Huge Liver Metastasis]. (2019/12/01) ♡
• Validation of Cell-Free DNA Collection Tubes for Determination of EGFR Mutation Status in Liquid Biopsy from NSCLC Patients. (2019/12/01) ♡
• Osteopontin Mediates Cetuximab Resistance via the MAPK Pathway in NSCLC Cells. (2019/11/26) ♡
• Neurological Death is Common in Patients With EGFR Mutant Non-Small Cell Lung Cancer Diagnosed With Brain Metastases. (2019/11/26) ♡
• A Cohort Study of Stereotactic Radiosurgery Results for Patients With 5 to 15 Versus 2 to 4 Brain Metastatic Tumors. (2019/11/26) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A prospective observational study of on-treatment plasma homocysteine levels as a biomarker of toxicity, depression and vitamin supplementation lead-in time pre pemetrexed, in patients with non-small cell lung cancer and malignant mesothelioma. (2019/11/25) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Radiotherapy in Lung Cancer: Current and Future Role. (2019/11/21) ♡
• Individual cristae within the same mitochondrion display different membrane potentials and are functionally independent. (2019/11/15) ♡
• Poor Prognosis With Coexistence Of EGFR T790M Mutation And Common EGFR-Activating Mutation In Non- Small Cell Lung Cancer. (2019/11/13) ♡
• Lung tumor cells inhibit bone mineralization and osteoblast activity. (2019/11/12) ♡
• The Ancient Chinese Decoction Yu-Ping-Feng Suppresses Orthotopic Lewis Lung Cancer Tumor Growth Through Increasing M1 Macrophage Polarization and CD4(+) T Cell Cytotoxicity. (2019/11/08) ♡
• High levels of EGFR prevent sulforaphane-induced reactive oxygen species-mediated apoptosis in non-small-cell lung cancer cells. (2019/11/01) ♡
• MiR-let-7a/f-CCR7 signaling is involved in the anti-metastatic effects of an herbal formula comprising Sophorae Flos and Lonicerae Japonicae Flos in melanoma. (2019/11/01) ♡
• Prognostic impact of prognostic nutritional index in advanced (stage IIIB/IV) non-small cell lung cancer patients. (2019/11/01) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.